haylaavo

LASA SUPERGENERICS

LASA · NSE
4.67
-0.24 (-4.89%)
as of 26 Oct 2026 close
Open
4.86
High
4.86
Low
4.67
Prev close
4.91
52w high
12.48
05 Jan 2026
52w low
4.67
26 Oct 2026
VWAP
4.72
Delivery %
—
n/a
Volume 42,091 · turnover ₹1.99 L · NSE bhavcopy (official close) · history since 21 Sept 2017
Market cap
₹23 cr
ISIN
INE670X01014
Series
BE
Listed on NSE
21 Sept 2017
Face value
₹10
F&O
No

Source: NSE equity master · as of 02 Nov 2026 · market cap = shares (30 Sept 2026 filing) × close

Market cap
₹23 cr
P/B
0.47
BV ₹10
ROE (TTM)
—
Debt / equity
0.20
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
—
Net profit TTM
—
Net margin TTM
—
EV / EBITDA
—
Interest cover
—
Revenue growth
—
latest quarter YoY
Profit growth
—
latest quarter YoY
Dividend yield
—
last 12 months

Standalone · last four quarters to 2026-06-30 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Shareholding · as of 30 Sept 2026
Promoters
53.65%
Public
46.35%
FPIs 0.00%
DIIs —
Mutual funds —
Insurance —
Retail 42.04%
Government —
26-09

Promoter share by quarter · source: NSE shareholding filings (XBRL). DIIs include mutual funds and insurers.

Quarterly results · Standalone · latest 30 Jun 2026

filed 14 Aug 2026, 07:02 pm IST
₹ croreDec 25*Mar 26Jun 26*
Revenue2-01
Other income000
Total expenses544
Operating margin-34.0%1963.0%-152.4%
Finance costs000
Depreciation212
Profit before tax-2-4-3
Tax000
Net profit-3-4-4
Net margin-116.2%3166.8%-291.7%
EPS (₹)-0.51-0.830.71

Annual results · 12-month figures as filed

₹ croreFY26
Revenue25
Other income0
Total expenses60
Operating margin-113.0%
Finance costs0
Depreciation6
Profit before tax-35
Tax-1
Net profit-34
Net margin-135.6%
EPS (₹)-6.80
Source and definitions

NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.

Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
  • P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
  • FII / DII / mutual fund split (from shareholding XBRL)
  • Peer comparison